Scholars Central

Conference abstractPublished 27 Jun 2024

Implementation and progress of SMA neonatal genetic screening in republic of moldova

Authors: Iulia Coliban, Biologist, Sacara Victoria

Mother and Child Institute, RM

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Spinal Muscular Atrophy (SMA) is a life-threatening autosomal recessive neuromuscular disorder, primarily caused by mutations in the SMN1 gene. Early detection of SMA through newborn screening (NBS) is essential to prevent irreversible neuronal damage, guide treatment and follow-up. Aim: to develop and implement a pilot newborn genetic screening program for SMA. Materials and Methods: The Human Molecular Genetics Lab at the Mother and Child Institute (IMC) undertook a pilot genetic screening approach for newborns, utilizing an algorithm designed for SMA mutation analysis. Newborn blood samples were collected on filter paper cards after securing informed consent. These samples were subjected to thorough analysis using advanced molecular-genetic methods, including qPCR and MLPA techniques. Results: The research design and protocol received approval from the Research Ethics Committee. The study successfully implemented necessary molecular genetic methods, including real-time PCR with specially designed probes and arrays. For comparison and validation, a commercial set was employed. The MLPA method was integral in confirming and assessing the copy number variations of SMN1/SMN2 genes. A total of 300 informed consents were obtained, and 265 samples screened. Three samples were flagged as potentially positive and one was confirmed as positive upon re-screening and then by MLPA Conclusions: The screening algorithm is primarily designed to detect spinal muscular atrophy (SMA) in newborns by identifying homozygous deletions in exon 7 of the SMN1 gene. About 5% of SMA cases with compound heterozygous mutations are undetected. This screening enables early identification of SMA, allowing for timely intervention. Implementing this screening at the IMC evaluates its practicality as an early diagnostic tool for SMA, potentially benefiting Moldova's healthcare system.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Pediatrics & Therapeutics.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPediatrics & Therapeutics
  • SubjectPaediatrics & Neonatology
  • BylineArticles whose byline prints “Iulia Coliban”
  • BylineArticles whose byline prints “Biologist”
  • BylineArticles whose byline prints “Sacara Victoria”